Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma
Cancer Commun (Lond). 2019 Oct 25;39(1):64.
doi: 10.1186/s40880-019-0398-0.
1 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, Guangdong, P. R. China.
2 Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, P. R. China.
3 Divisions of Radiation Oncology and Medical Sciences, National Cancer Centre Singapore, Singapore, 169610, Singapore.
4 Oncology Academic Programme, Duke-National University of Singapore Medical School, Singapore, 169857, Singapore.
5 Institute Gustave-Roussy, 94800, Villejuif, France.
6 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, 510060, Guangdong, P. R. China. maihq@sysucc.org.cn.
7 Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, P. R. China. maihq@sysucc.org.cn.